| Literature DB >> 35097108 |
Abstract
BACKGROUND: The emergence of multi-drug-resistant organisms has created a lot of clinical problems. Hence, there is a need to find natural alternative treatment to counter the multi-drug-resistant organisms. Honey has a well-established usage as wound dressing in ancient and traditional medicine.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35097108 PMCID: PMC8799333 DOI: 10.1155/2022/1560050
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Thirty-two different global honey samples collected from different countries.
| Code | Locality | Source | Floral origin pH |
|---|---|---|---|
| A | Sudan | East Singa | Neem 3.4 |
| B | Sudan | East Singa | Sidr 4.6 |
| C | Sudan | East Singa | Sidr 4.9 |
| D1 | Sudan | Damazine east | Sidr 4.7 |
| D2 | Sudan | West apiary | Acacia 4.3 |
| E | Sudan | West Darfur apiary | Sidr 4.5 |
| F | Sudan | West Darfur apiary | Mountain 4.6 |
| G | Sudan | South apiary | Acacia 4.2 |
| H | Sudan | Darfur apiary | Acacia 3.5 |
| I1 | Saudi Arabia | College of Agriculture apiary | Sun flower 3.5 |
| I2 | Saudi Arabia | College of Agriculture apiary | Sun flower 3.5 |
| J | Kashmir | Commercial | Sun flower 3.5 |
| K | Yemen | Apiary | Sidr 3.5 |
| L1 | Kashmir | Apiary | Sidr 3.5 |
| L2 | India | Apiary | Unknown 3.5 |
| M | Iran | Commercial | Sidr 4.2 |
| N | Turkey | Commercial | Orange 3.5 |
| O | Saudi Arabia | Al-Shifa commercial | Flowers 4.2 |
| P | Australia | Commercial | Flowers 4.1 |
| Q | Argentine | Commercial | Orange 4.3 |
| R | Saudi Arabia | Al-Shifa commercial | Orange 4.0 |
| S | United stated | Goody commercial | Flowers 3.8 |
| T1 | Germany | Langnese commercial | Flowers 3.7 |
| T2 | Germany | Langnese commercial | Flowers 3.7 |
| U | Saudi Arabia | Al-Shifa commercial | Acacia 4.2 |
| V | Palestinian | Apiary | Citrus 4.2 |
| W1 | Egypt | Apiary | Alfa 4.6 |
| W2 | Egypt | Apiary | Alfa 4.5 |
| X | Jordan | Apiary | Citrus 4.5 |
| Y1 | Yemen | Apiary | Sidr 4.4 |
| Y2 | Yemen | Commercial | Sidr 4.5 |
| Z | Saudi Arabia | Tabuk apiary | Sun flower 4.3 |
Antibacterial activity of 32 bee honeys against 8 clinical isolates.
| Honey samples | Bacterial strain | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| MRSA | |
| Inhibition zone in mm ± (SD) | ||||||||
|
| ||||||||
| A | 25 ± (0.5) | 22 ± (0.5) | 22 ± (0.5) | 25 ± (0.5) | 23 ± (0.5) | 21 ± (0.5) | 22 ± (0.5) | 24 ± (0.5) |
| B | 25 ± (0.7) | 20 ± (0.5) | 21 ± (0.6) | 24 ± (0.6) | 22 ± (0.5) | 22 ± (0.5) | 23 ± (0.5) | 25 ± (0.6) |
| C | 24 ± (0.5) | 24 ± (0.5) | 21 ± (0.5) | 31 ± (0.6) | 24 ± (0.5) | 19 ± (0.5) | 24 ± (0.5) | 23 ± (0.6) |
| D1 | 22 ± (0.5) | 19 ± (0.5) | 20 ± (0.5) | (0.5)38± | 25 ± (0.6) | 20 ± (0.5) | 22 ± (0.5) | 22 ± (0.5) |
| D2 | 24 ± (0.5) | 20 ± (0.5) | 21 ± (0.5) | 27 ± (0.4) | 24 ± (0.4) | 25 ± (0.5) | 24 ± (0.4) | 21 ± (0.5) |
| E | (0.5)24± | 19 ± (0.5) | 20 ± (0.5) | 28 ± (0.6) | 23 ± (0.5) | 22 ± (0.4) | 23 ± (0.6) | 22 ± (0.4) |
| F | 25 ± (0.6) | 20 ± (0.5) | 21 ± (0.5) | 26 ± (0.5) | 22 ± (0.4) | 22 ± (0.5) | 22 ± (0.4) | 24 ± (0.5) |
| G | 23 ± (0.5) | 25 ± (0.4) | 22 ± (0.5) | 25 ± (0.4) | 23 ± (0.5) | 23 ± (0.4) | 21 ± (0.4) | 25 ± (0.5) |
| H | 24 ± (0.4) | 22 ± (0.5) | 21 ± (0.4) | 21 ± (0.4) | 23 ± (0.5) | 21 ± (0.5) | 20 ± (0.5) | 23 ± (0.5) |
| I1 | 26 ± (0.5) | 23 ± (0.6) | 22 ± (0.4) | 23 ± (0.6) | 24 ± (0.4) | 22 ± (0.4) | 22 ± (0.4) | 24 ± (0.6) |
| I2 | 27 ± (0.5) | 22 ± (0.5) | 23 ± (0.6) | 23 ± (0.5) | 25 ± (0.5) | 23 ± (0.6) | 23 ± (0.5) | 21 ± (0.5) |
| J | 23 ± (0.6) | 21 ± (0.5) | 22 ± (0.5) | 25 ± (0.6) | 26 ± (0.5) | 24 ± (0.5) | 25 ± (0.5) | 22 ± (0.5) |
| K | 24 ± (0.4) | 18 ± (0.5) | 23 ± (0.6) | 24 ± (0.4) | 24 ± (0.6) | 25 ± (0.6) | 22 ± (0.4) | 23 ± (0.5) |
| L1 | 22 ± (0.4) | 17 ± (0.4) | 23 ± (0.5) | 24 ± (0.4) | 24 ± (0.5) | 23 ± (0.4) | 21 ± (0.5) | 24 ± (0.4) |
| L2 | 22 ± (0.6) | 22 ± (0.5) | 22 ± (0.5) | 22 ± (0.4) | 25 ± (0.5) | 24 ± (0.4) | 23 ± (0.5) | 22 ± (0.4) |
| M | 23 ± (0.5) | 22 ± (0.5) | 23 ± (0.5) | 20 ± (0.4) | 23 ± (0.5) | 22 ± (0.4) | 24 ± (0.5) | 21 ± (0.4) |
| N | 22 ± (0.5) | 23 ± (0.5) | 22 ± (0.5) | 24 ± (0.4) | 24 ± (0.5) | 23 ± (0.5) | 23 ± (0.5) | 23 ± (0.5) |
| O | 21 ± (0.4) | 20 ± (0.5) | 23 ± (0.5) | 23 ± (0.4) | 24 ± (0.5) | 21 ± (0.4) | 22 ± (0.5) | 25 ± (0.4) |
| P | 23 ± (0.5) | 21 ± (0.5) | 23 ± (0.5) | 23 ± (0.5) | 23 ± (0.4) | 22 ± (0.4) | 21 ± (0.4) | 24 ± (0.4) |
| Q | 24 ± (0.5) | 20 ± (0.5) | 21 ± (0.6) | 23 ± (0.5) | 25 ± (0.5) | 23 ± (0.6) | 22 ± (0.5) | 23 ± (0.5) |
| R | 23 ± (0.6) | 21 ± (0.5) | 22 ± (0.4) | 22 ± (0.5) | 22 ± (0.5) | 23 ± (0.4) | 23 ± (0.4) | 22 ± (0.5) |
| S | 24 ± (0.5) | 22 ± (0.5) | 24 ± (0.4) | 23 ± (0.5) | 23 ± (0.6) | 22 ± (0.5) | 24 ± (0.6) | 21 ± (0.4) |
| T1 | 25 ± (0.4) | 20 ± (0.5) | 22 ± (0.6) | 22 ± (0.5) | 24 ± (0.5) | 24 ± (0.5) | 23 ± (0.5) | 24 ± (0.5) |
| T2 | 24 ± (0.6) | 21 ± (0.5) | 21 ± (0.4) | 25 ± (0.5) | 25 ± (0.4) | 23 ± (0.5) | 22 ± (0.5) | 24 ± (0.6) |
| U | 25 ± (0.5) | 22 ± (0.6) | 21 ± (0.5) | 24 ± (0.5) | 24 ± (0.5) | 22 ± (0.5) | 23 ± (0.4) | 25 ± (0.5) |
| V | 23 ± (0.5) | 21 ± (0.4) | 22 ± (0.5) | 25 ± (0.4) | 22 ± (0.5) | 24 ± (0.6) | 22 ± (0.5) | 23 ± (0.6) |
| W1 | 22 ± (0.5) | 22 ± (0.5) | 20 ± (0.5) | 24 ± (0.5) | 21 ± (0.5) | 22 ± (0.4) | 21 ± (0.5) | 22 ± (0.5) |
| W2 | 21 ± (0.5) | 20 ± (0.6) | 21 ± (0.5) | 23 ± (0.6) | 23 ± (0.5) | 21 ± (0.5) | 22 ± (0.5) | 21 ± (0.4) |
| X | 24 ± (0.6) | 22 ± (0.4) | 22 ± (0.5) | 22 ± (0.5) | 24 ± (0.4) | 22 ± (0.5) | 23 ± (0.5) | 22 ± (0.6) |
| Y1 | 23 ± (0.5) | 21 ± (0.5) | 21 ± (0.5) | 23 ± (0.5) | 22 ± (0.5) | 22 ± (0.6) | 24 ± (0.5) | 23 ± (0.5) |
| Y2 | 22 ± (0.4) | 20 ± (0.5) | 21 ± (0.4) | 22 ± (0.6) | 21 ± (0.5) | 21 ± (0.5) | 23 ± (0.5) | 21 ± (0.4) |
| Z | 23 ± (0.5) | 22 ± (0.4) | 21 ± (0.4) | 22 ± (0.5) | 21 ± (0.5) | 23 ± (0.5) | 22 ± (0.4) | 21 ± (0.5) |
Minimum inhibitory concentration of 6 antibiotics against 8 clinical isolates (Etest).
| Antibiotics | Bacterial strains | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| MSSA | MRSA | |
| MIC (mg/l) | ||||||||
|
| ||||||||
| Amoxicillin | 3 | 3 | 0.125 | 1.5 | 0.6 | 3 | 4 | 0.125 |
| Ciprofloxacin | 2 | 0.125 | 0.5 | 2.5 | 0.18 | 0.125 | 3 | 0.50 |
| Cefotaxime | 0.5 | 0.6 | 0.125 | 0.6 | 0.125 | 0.125 | 3 | 1.0 |
| Chloramphenicol | 1.5 | 3 | 0.50 | 3 | 2 | 1.5 | 0.125 | 3 |
| Gentamicin | 3 | 1.5 | 0.50 | 0.125 | 1.5 | 0.125 | 3 | 3 |
| Tetracycline | 4 | 1.5 | 0.064 | 0.125 | 0.50 | 0.50 | 0.125 | 1.0 |